Skip to main content
. 2006 Aug 29;95(6):699–704. doi: 10.1038/sj.bjc.6603323

Figure 3.

Figure 3

Progression-free survival (PFS) for patients with optimally debulked early ovarian carcinoma undergoing systematic aortic and pelvic lymphadenectomy (Lymphad.) vs lymph nodes sampling only (No lymphad.). Five-year progression-free survival was 73.4 and 78.3% (difference=4.9%, 95% CI=−5.9 to 12.5%) respectively, for lymph nodes sampling only and lymphadenectomy.